Enveric Biosciences (ENVB) Accumulated Expenses (2015 - 2024)
Enveric Biosciences (ENVB) reported Accumulated Expenses of $732,010 for Q4 2024, down 31.9% from $1.08 million a year earlier but up 189.2% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Accumulated Expenses (2015 - 2024) Analysis & Trends
Dating back to Q4 2015, Enveric Biosciences' Accumulated Expenses record includes 17 quarters.
- Accumulated Expenses has a three-year compound annual growth rate of -17.3% (FY2021 to FY2024).
- By year, Accumulated Expenses came in at $1.08 million in FY2023 (-36.9%), $1.71 million in FY2022 (+31.9%) and $1.29 million in FY2021.
- Five-year quarterly Accumulated Expenses spans a low of $176,373 in Q2 2024 and a high of $1.71 million in Q4 2022.
- Year over year, Accumulated Expenses has now declined in each of the last five quarters, with an average decline of 21.4% over the last eight quarters.
- The high point for year-over-year Accumulated Expenses in five years was Q2 2023 (growth of 49.3%); the low point was Q2 2024 (a decline of 88.2%).
- Per Business Quant data, the three quarters before Q4 2024 came in at $253,150 (Q3 2024), $176,373 (Q2 2024) and $487,464 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 732,010.00 |
| Sep 30, 2024 | 253,150.00 |
| Jun 30, 2024 | 176,373.00 |
| Mar 31, 2024 | 487,464.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.03 Mn |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 764,022.00 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2016 | 1.35 Mn |
| Jun 30, 2016 | 1.42 Mn |
| Mar 31, 2016 | 2.24 Mn |
| Dec 31, 2015 | 1.09 Mn |
API Access
Enveric Biosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();